OB/GYN screening may help detect heart disease risk

March 26, 2012

Simple screening implemented in obstetrics and gynecology (OB/GYN) clinics may identify previously undetected heart disease risk among women and has the potential to greatly increase education about prevention and treatment of cardiovascular disease in female patients, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field.

Heart disease is the leading cause of death among women in the United States, and the rate of heart disease deaths in women aged 35 to 44 continues to increase by approximately 1 percent each year. Currently, many women are undertreated or remain unaware of their heart disease risk factors.

"There is a real disparity in the medical community where we tend to think heart disease is a disease of men, and historically we have not done a very good job of screening women for ," said Roxana Mehran, MD, director of interventional cardiovascular research and clinical trials, Mount Sinai Medical Center, and the study's principal investigator. "It often doesn't occur to women that they could have a until their symptoms are very advanced, so we have to think differently and be creative about how we identify, educate and treat women at risk."

Researchers implemented a at 10 OB/GYN clinics to screen women for cardiovascular risk factors or disease. From January 2010 to January 2012, 2,234 women (47 percent of whom were postmenopausal) were asked to complete a simple, one-page survey regarding traditional and gestational heart disease risk factors and any current symptoms. were taken in all patients with no prior screening. Cardiovascular risk factors and symptoms were common (69 percent and 42 percent, respectively) among middle-aged women screened in the pilot, suggesting that cardiovascular assessment in the setting of OB/GYN clinics may enhance the delivery of primary prevention and education to female patients.

Of the women screened, 18 percent considered their OB/GYN as their primary health care provider. A significant proportion of screened patients either did not know or had never had testing of their blood pressure, cholesterol or blood sugar levels (21, 38, and 19 percent respectively). After the screening process, 25 percent of patients were referred to another health provider (primary care physician, cardiologist, endocrinologist, or other) for further evaluation and treatment of factors.

"We found a real lack of awareness among many of these women that they had risk factors, including diabetes, high blood pressure and high cholesterol. OB/GYN practices have an incredible opportunity to make an impact on in women by screening, educating and directing women to the right providers, so we hope to see continued research in this area," Dr. Mehran said.

In particular, she said future trials should involve a larger patient pool in order to demonstrate an improvement of clinical outcomes in with cardiovascular disease.

Explore further: Women's risk of heart disease after gestational diabetes differs by race

Related Stories

Women's risk of heart disease after gestational diabetes differs by race

June 6, 2011
New research finds that gestational diabetes, or pregnancy-related diabetes, may not raise the risk of heart disease independent of other cardiovascular risk factors except in certain high-risk populations, such as Hispanics. ...

Diabetes associated with higher risk of cardiovascular problems in men

March 25, 2012
According to a new study by researchers at Brigham and Women's Hospital (BWH), men with type 2 diabetes treated with insulin without a history of cardiovascular disease (CVD) were at higher risk for major cardiovascular events ...

Many women having a heart attack don't have chest pain

February 21, 2012
(HealthDay) -- Two out of five women having a heart attack do not experience chest pain, according to a new study.

Simple, common BMI data stored in e-records can identify patients with heart disease risk

March 13, 2012
Electronic medical records provide new opportunities to monitor and improve patients’ health. New research released online in the American Journal of Preventive Medicine shows that body mass index (BMI) data, commonly ...

Atrial fibrillation associated with increased risk of death and cardiovascular events in women

May 24, 2011
Researchers at Brigham and Women's Hospital (BWH) have found that among women who are mostly healthy, those diagnosed with atrial fibrillation have an increased risk of death when compared to women without atrial fibrillation. ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.